Recurrence and Outcomes of Complement-Related Renal Disease After Pediatric Renal Transplantation.
Authors:
- Kaan GullerogluKGKaan Gulleroglu
- Esra BaskinEBEsra Baskin
- Handan OzdemirHOHandan Ozdemir
- Gokhan MorayGMGokhan Moray
- Mehmet HaberalMHMehmet Haberal
- 1 January 2020
- journal article
- research article
- Published by Baskent University in Experimental and Clinical Transplantation
- Vol. 18 (Suppl 1) , 82-83
Abstract
Complement dysregulation is related to different glomerular pathologies. Patients with complement dysregulation have high recurrence risk after transplant; however, with trough-effective therapeutics, renal transplant can be an option for these patients. Here, we present 2 boys with renal disease related to complement dysregulation and their outcomes after renal transplant. Patient 1 had atypical hemolytic uremic syndrome, which was treated with eculizumab before renal transplant; eculizumab therapy was also continued after transplant as preventive therapy. Eculizumab therapy was stopped at year 2 post-transplant. At year 4 post-transplant, his serum creatinine level was 0.87 mg/dL. Patient 2, who had chronic renal disease related to C3 glomerulopathy, was not responsive to eculizumab before renal transplant. At month 4 posttransplant, C3 glomerulopathy recurrence was demonstrated with biopsy, and serum creatinine level was 1.96 mg/dL at this time. Eculizumab was started as a rescue therapy. At year 4 posttransplant, his serum creatinine level was 2.07 mg/dL. In our 2 patients with complement dysregulation, eculizumab was an effective and preventive therapy after renal transplant. However, more studies are needed to understand the long-term efficacy and safety of eculizumab after renal transplant.Keywords
This publication has 6 references indexed in Scilit:
- Complement Dysregulation and Disease: Insights from Contemporary GeneticsAnnual Review of Pathology: Mechanisms of Disease, 2017
- Timing of eculizumab therapy for C3 glomerulonephritisClinical Kidney Journal, 2015
- Complement Genes Strongly Predict Recurrence and Graft Outcome in Adult Renal Transplant Recipients with Atypical Hemolytic and Uremic SyndromeAmerican Journal of Transplantation, 2013
- Recurrent Dense Deposit Disease After Renal Transplantation: An Emerging Role for Complementary TherapiesAmerican Journal of Transplantation, 2012
- Recurrence of Complement Factor H-Related Protein 5 Nephropathy in a Renal TransplantAmerican Journal of Transplantation, 2011
- Disease recurrence in paediatric renal transplantationPediatric Nephrology, 2009